100 related articles for article (PubMed ID: 17390038)
1. Immunoexpression of lactoferrin in human sporadic renal cell carcinomas.
Giuffrè G; Barresi V; Skliros C; Barresi G; Tuccari G
Oncol Rep; 2007 May; 17(5):1021-6. PubMed ID: 17390038
[TBL] [Abstract][Full Text] [Related]
2. Lactoferrin immunoexpression in endometrial carcinomas: relationships with sex steroid hormone receptors (ER and PR), proliferation indices (Ki-67 and AgNOR) and survival.
Giuffrè G; Arena F; Scarfì R; Simone A; Todaro P; Tuccari G
Oncol Rep; 2006 Aug; 16(2):257-63. PubMed ID: 16820900
[TBL] [Abstract][Full Text] [Related]
3. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
[TBL] [Abstract][Full Text] [Related]
4. Alpha-methyl CoA racemase expression in renal cell carcinomas.
Molinié V; Balaton A; Rotman S; Mansouri D; De Pinieux I; Homsi T; Guillou L
Hum Pathol; 2006 Jun; 37(6):698-703. PubMed ID: 16733210
[TBL] [Abstract][Full Text] [Related]
5. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
6. Ghrelin expression in normal kidney tissue and renal carcinomas.
Dagli AF; Aydin S; Karaoglu A; Akpolat N; Ozercan IH; Ozercan MR
Pathol Res Pract; 2009; 205(3):165-73. PubMed ID: 19054628
[TBL] [Abstract][Full Text] [Related]
7. Kit (CD117) immunoreactivity is rare in renal cell and upper urinary tract transitional cell carcinomas.
Zigeuner R; Ratschek M; Langner C
BJU Int; 2005 Feb; 95(3):315-8. PubMed ID: 15679785
[TBL] [Abstract][Full Text] [Related]
8. BIGH3 is overexpressed in clear cell renal cell carcinoma.
Yamanaka M; Kimura F; Kagata Y; Kondoh N; Asano T; Yamamoto M; Hayakawa M
Oncol Rep; 2008 Apr; 19(4):865-74. PubMed ID: 18357369
[TBL] [Abstract][Full Text] [Related]
9. Mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type II expression in renal cell neoplasms: a tissue microarray and quantitative RT-PCR study.
Yakirevich E; Morris DJ; Tavares R; Meitner PA; Lechpammer M; Noble L; de Rodriguez AF; Gomez-Sanchez CE; Wang LJ; Sabo E; Delellis RA; Resnick MB
Am J Surg Pathol; 2008 Jun; 32(6):874-83. PubMed ID: 18408592
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma.
Ohno Y; Izumi M; Yoshioka K; Ohori M; Yonou H; Tachibana M
Oncol Rep; 2008 Sep; 20(3):511-6. PubMed ID: 18695899
[TBL] [Abstract][Full Text] [Related]
11. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity.
Gobbo S; Eble JN; Grignon DJ; Martignoni G; MacLennan GT; Shah RB; Zhang S; Brunelli M; Cheng L
Am J Surg Pathol; 2008 Aug; 32(8):1239-45. PubMed ID: 18594469
[TBL] [Abstract][Full Text] [Related]
12. Immunolocalization of lactoferrin in surgically resected pigmented skin lesions.
Tuccari G; Giuffrè G; Scarf R; Simone A; Todaro P; Barresi G
Eur J Histochem; 2005; 49(1):33-8. PubMed ID: 15823792
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of Id-1 and its association with EGFR in renal cell cancer.
Li X; Zhang Z; Xin D; Chua CW; Wong YC; Leung SC; Na Y; Wang X
Histopathology; 2007 Mar; 50(4):484-90. PubMed ID: 17448024
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
Nakada C; Matsuura K; Tsukamoto Y; Tanigawa M; Yoshimoto T; Narimatsu T; Nguyen LT; Hijiya N; Uchida T; Sato F; Mimata H; Seto M; Moriyama M
J Pathol; 2008 Dec; 216(4):418-27. PubMed ID: 18925646
[TBL] [Abstract][Full Text] [Related]
15. Claudin-1 protein expression is a prognostic marker of patient survival in renal cell carcinomas.
Fritzsche FR; Oelrich B; Johannsen M; Kristiansen I; Moch H; Jung K; Kristiansen G
Clin Cancer Res; 2008 Nov; 14(21):7035-42. PubMed ID: 18981000
[TBL] [Abstract][Full Text] [Related]
16. Renal cell carcinomas with papillary architecture and clear cell components: the utility of immunohistochemical and cytogenetical analyses in differential diagnosis.
Gobbo S; Eble JN; Maclennan GT; Grignon DJ; Shah RB; Zhang S; Martignoni G; Brunelli M; Cheng L
Am J Surg Pathol; 2008 Dec; 32(12):1780-6. PubMed ID: 18779729
[TBL] [Abstract][Full Text] [Related]
17. Renal cell carcinoma marker (RCC-Ma) is specific for cutaneous metastasis of renal cell carcinoma.
Perna AG; Ostler DA; Ivan D; Lazar AJ; Diwan AH; Prieto VG; Reed JA
J Cutan Pathol; 2007 May; 34(5):381-5. PubMed ID: 17448192
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
Klatte T; Seligson DB; Riggs SB; Leppert JT; Berkman MK; Kleid MD; Yu H; Kabbinavar FF; Pantuck AJ; Belldegrun AS
Clin Cancer Res; 2007 Dec; 13(24):7388-93. PubMed ID: 18094421
[TBL] [Abstract][Full Text] [Related]
19. Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1 alpha.
Lidgren A; Bergh A; Grankvist K; Rasmuson T; Ljungberg B
BJU Int; 2008 Feb; 101(4):480-4. PubMed ID: 17922867
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical evidence of lactoferrin in human embryo-fetal bone and cartilage tissues.
Antonio I; Valeria B; Maddalena G; Giovanni T
Cell Biol Int; 2010 Aug; 34(8):845-9. PubMed ID: 20443779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]